Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
XOMA Ltd (XOMA)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: XOMA
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Readers Ask: Antares, GenVec, Xoma,
VFC's Stock House
•
Sep 13
•
12 Comments
Closing Update for Wednesday, Sept. 9
Midnight Trader
•
Sep 09
•
Comment!
ADA Meeting 2009: Novel Diabetes Therapies Presented
Michael Becker
•
Jun 24
•
1 Comment
Friday's BioPlay: Xoma Ltd.
M. E. Garza
•
Jun 05
•
2 Comments
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
Mike Havrilla
•
May 15
•
Comment!
Race to Develop Bioterrorism Vaccine
Douglas Cress
•
Mar 11
•
4 Comments
More articles on XOMA »
Latest Transcript
XOMA Ltd. Q3 2009 Earnings Call Transcript
Mon November 9, 2009
More transcripts on XOMA »
Instablogs
XOMA (XOMA): WHAT DO WE NEED FROM THIS FIRM?
Mon September 21, 2009
•
Prohost Biotech
•
1 Comment
Novel Diabetes Therapies Presented at the 2009 ADA Meeting
Tue June 23, 2009
•
Michael Becker
•
Comment!
MD Becker Partners' biotechnology sector movers - closing report
Mon June 15, 2009
•
Michael Becker
•
Comment!
Write a post on XOMA
|
More Instablogs on XOMA »
Sentiment
What advice would you give to
XOMA?
123 characters left
What's your view of XOMA?
Make sure you include XOMA
140 characters left
|
Settings
domenick
:
XOMA
052 Selected as a Top Ten Project to Watch GlobeNewswire
http://tinyurl.com/y9lhzxa
Fri, Nov 13, 2009
mbmalone
: The
CEO
has a wholly inadequate ability to market
XOMA
052 to potential partners and should rank as a finalist for worst
CEO
of the year.
Mon, Nov 09, 2009
More StockTalks on XOMA »